Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1732185

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1732185

Global Amniocentesis Needle Market Size By Type, By Procedure, By End-User, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Amniocentesis Needle Market Size And Forecast

Amniocentesis Needle Market size was valued at USD 181.43 Million in 2024 and is projected to reach USD 220.15 Million by 2032, growing at a CAGR of 2.7% from 2026 to 2032.

Global Amniocentesis Needle Market Drivers

The market drivers for the Amniocentesis Needle Market can be influenced by various factors. These may include:

Growing Maternal Age: Prenatal diagnostic treatments like amniocentesis, which evaluate foetal health, genetic abnormalities, and other disorders, are becoming more and more popular as women put off having children for a variety of reasons.

Prevalence of Genetic Disorders: Prenatal diagnostic techniques like amniocentesis are necessary for the early detection and treatment of genetic disorders and chromosomal abnormalities, such as Down syndrome, spina bifida, and others, due to their increasing incidence.

Technological Developments: Amniocentesis needle technology has advanced to produce thinner, more accurate needles, better imaging methods, and a lower risk of problems. These developments make the process safer and more accurate, which in turn accelerates market growth.

Expanding Awareness: Prenatal screening and diagnosis's role in preventing or treating foetal anomalies and birth defects is being increasingly recognised by pregnant parents and medical professionals, which supports the market's growth.

Government Initiatives and Healthcare Policies: By lowering the cost and increasing the accessibility of prenatal testing methods, particularly for high-risk pregnancies, government initiatives, healthcare policies, and reimbursement programmes can substantially propel market expansion.

Growing Healthcare Expenditure: More people can now obtain sophisticated prenatal care and diagnostic procedures, such as amniocentesis, thanks to rising healthcare spending, especially in emerging nations.

Prevalence of Lifestyle disorders: The need for prenatal diagnostic techniques like amniocentesis is fueled by the rising prevalence of disorders linked to a lifestyle and environmental factors that impact foetal health, such as mother obesity, diabetes, and exposure to pollutants.

Increase in Pregnancy Rates: The market for amniocentesis needles is growing as a result of the general increase in pregnancy rates, which is being driven by factors like population growth, improvements in fertility treatments, and shifting societal standards.

Positive Regulatory Environment: By boosting customer trust and easing product uptake, regulatory approvals and guidelines guaranteeing the safety and effectiveness of amniocentesis procedures and related technologies promote market growth.

Global Amniocentesis Needle Market Restraints

Several factors can act as restraints or challenges for the Amniocentesis Needle Market. These may include:

Regulatory Obstacles: Tight rules governing medical devices and practices can cause difficulties for producers and healthcare practitioners, resulting in approval delays or higher compliance costs.

Risk of Complications: Miscarriage is one of the hazards associated with amniocentesis, despite it being a regular treatment. The market potential may be limited if expecting mothers are discouraged from undergoing the treatment due to concerns about the associated hazards.

Alternative Screening Technologies: The necessity for amniocentesis needles may be decreased by the development of non-invasive prenatal testing (NIPT) and other screening technologies as alternatives to conventional amniocentesis.

Ethical and Social Considerations: Patients' and healthcare professionals' decisions may be influenced by ethical concerns about prenatal testing and the possible ramifications of detecting specific genetic abnormalities. This could have an effect on the demand for amniocentesis operations.

Cost Restrictions: Amniocentesis treatments can be costly, particularly for those without sufficient insurance. Access to these operations may be restricted due to cost, especially in areas with less developed healthcare systems or lower socioeconomic status.

Technological Challenges: Amniocentesis is a well-established procedure, but to increase safety and accuracy, continuous improvements in needle design and imaging technology would be needed. High research and development expenses or technological constraints, however, may prevent the creation of such advances.

Patient Anxiety and Fear: Some people may be discouraged from having amniocentesis due to fear of the procedure's pain or discomfort or worry about the procedure's possible outcomes, which could impact market demand.

Low Knowledge and Education: Underutilization of amniocentesis may be caused by low knowledge among patients and healthcare professionals on the advantages, dangers, and indications of the treatment, especially in areas with limited access to prenatal care or educational resources.

Global Amniocentesis Needle Market: Segmentation Analysis

The Global Amniocentesis Needle Market is Segmented on the basis of Type, Procedure, End-User, and Geography.

Amniocentesis Needle Market, By Type

100-150 mm Needles

  • Larger Than 150 mm Needles
  • Smaller Than 100 mm Needles

Based on Type, the market is bifurcated into 100-150 mm Needles, Larger than 150 mm Needles, and Smaller Than 100 mm Needles. The 100-150 mm needles segment is expected to hold the largest market share. The factors can be attributed to the suitability of use for most patients and the widespread use of these needles on account of their optimal length.

Amniocentesis Needle Market, By Procedure

  • Amniocentesis Procedures
  • Amnioinfusion Procedures
  • Amnioreduction Procedures
  • Cordocentesis Procedures
  • Fetal Blood Transfusion Procedures

Based on the Procedure, the market is bifurcated into Amniocentesis Procedures, Amnioinfusion Procedures, Amnioreduction Procedures, Cordocentesis Procedures, and Fetal Blood Transfusion Procedures. Amniocentesis Procedures are predicted to hold the most significant CAGR in the forecasted period due to the extensive use of this procedure to diagnose the abnormalities in the developing fetus and the high reliability of the amniocentesis technique.

Amniocentesis Needle Market, By End-User

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Others

Based on End-User, the market is bifurcated into Hospitals, Diagnostic Centers, Clinics, and Others. Hospitals are anticipated to hold the largest market share. The factors can be credited to the rising number of hospitals and better accessibility & availability of test results in hospitals.

Amniocentesis Needle Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on regional analysis, the Global Amniocentesis Needle Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to the growing healthcare expenditure and increasing government initiatives in this region.

Key Players

  • The major players in the Amniocentesis Needle Market are:
  • Becton Dickinson and Company
  • Cook Medical
  • MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Biopsybell
  • Integra Lifesciences
  • Rocket Medical plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: 32507

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL AMNIOCENTESIS NEEDLE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AMNIOCENTESIS NEEDLE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2100-150 mm Needles
  • 5.3 Larger Than150 mm Needles
  • 5.4 Smaller Than100 mm Needles

6 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY PROCEDURE

  • 6.1 Overview
  • 6.2 Amniocentesis Procedures
  • 6.3 Amnioinfusion Procedures
  • 6.4 Amnioreduction Procedures
  • 6.5 Cordocentesis Procedures
  • 6.6 Fetal Blood Transfusion Procedures

7 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers
  • 7.4 Clinics
  • 7.5 Others

8 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL AMNIOCENTESIS NEEDLE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Cook Medical
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 RI.MOS. Srl
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Smiths Medical
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Laboratoire Ccd
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Biopsybell
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Integra Lifesciences
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Medtronic Plc
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Coopersurgical
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Medline
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!